All News

In a systematic review of antibiotic drug shortages, researchers explored what causes them, how they impact health systems, and what officials commonly do to mitigate them.

Researchers explored the efficacy of a multidisciplinary pain management team for addressing patients with cancer-related pain.

The results of this study show that the concurrent presence of asthma and obesity did not synergistically amplify inflammation in children with both asthma and overweight/obesity.

Miudella achieves similar efficacy to other available copper IUDs with less than half the dose of copper.

Among postmenopausal women, researchers investigated the association of cardiometabolic parameters and circulating levels of visfatin, adropin, and adiponectin.

The increased risk of symptoms only includes respiratory-related symptoms or brain fog.

The technology will be available to patients in the United States in March 2025.

Crystal Zhou, PharmD, APh, AHSCP, BCACP, joined Drug Topics to further discuss the Cut Hypertension Program and nontraditional roles within health care.

Meloxicam and rizatriptan (Symbravo, formerly AXS-07) is a CGRP medication approved for the acute treatment of migraine with or without aura.

The next-gen molecular Metrix was given emergency use authorization for its ability to test for SARS-CoV-2 and influenza A and B viruses.

Yesintek from Biocon Biologics and Pyzchiva from Sandoz will have a patient assistance program that includes benefits verification and copay support.

The updated label also includes alternative injection sites, such as the abdomen, thigh, buttock, or back of the upper arm.

Researchers explore the unification of outpatient practices and the structural racism in large health systems that has caused patient disparities.

Researchers identified factors contributing to Medicaid Managed Care complexities and collected evidence of pharmacists’ ability to address patients’ health needs.

The study authors report that long-term daily administration of amlodipine induced behavioral changes in the rats during their open field test.

Pharmacists who participated in the mental health first aid training had better understanding of mental health conditions and increased confidence and skills in mental health intervention.

Ctexli is the first FDA-approved treatment for adults with cerebrotendinous xanthomatosis.

Semaglutide has been in shortage since 2022 due to increased demand.

Physician with expertise in pain research discussed emerging technologies in the future of pain medicine and how they must be adapted to improve patient outcomes.

Measles is highly contagious, and the Texas Department of State Health Services said that additional cases are likely to occur in Gaines County, which had 57 cases as of February 21, 2025.

Experts gathered to explore the pathophysiology and therapeutic management of burn injury-induced pain.

Tirzepatide (Mounjaro, Zepbound), a glucagon-like peptide-1 (GLP-1) medication, demonstrates improved diabetes control and decreases in insulin requirements.

A program that includes peer coaching and monitoring tools can help pharmacists better manage hypertension in patients.

Researchers conducted a literature review to explore topics in entrepreneurship that impact pharmacy practice and education.

A recent metanalysis found that patients with type 1 diabetes had a 50% higher chance of developing dementia.

By 12 weeks, investigators report that SkinTE facilitated significantly more wound closures compared with the standard of care.

A conversation with Ginger Lemay, PharmD, Jeffrey Bratberg, PharmD, and Audrey Whalen, PharmD.

Researchers measured current pharmacy practices and the future potential of practices geared toward reducing instances of opioid overdose.